SEC Form 4 · accession 0001209191-18-062491
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pritesh Shah
Officer — Chief Commercial Officer
Period of report
Dec 12, 2018
Accepted (ET)
Dec 13, 2018 · 5:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Dec 12, 2018 | M | 22,532 | $7.48 | A | 39,619 | D | |
| Ordinary SharesF1 | Dec 12, 2018 | S | 21,382 | $36.00 | D | 18,237 | D | |
| Ordinary SharesF1 | Dec 12, 2018 | S | 1,150 | $36.01 | D | 17,087 | D | |
| Ordinary SharesF1 | Dec 12, 2018 | M | 16,249 | $7.15 | A | 33,336 | D | |
| Ordinary SharesF1 | Dec 12, 2018 | S | 15,419 | $36.00 | D | 17,917 | D | |
| Ordinary SharesF1 | Dec 12, 2018 | S | 830 | $36.01 | D | 17,087 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Ordinary SharesF2 | $7.48 | Dec 12, 2018 | M | 22,532 | D | — | Feb 25, 2024 | Ordinary Shares | 22,532 | 0 | D |
| Options to Buy Ordinary SharesF2 | $7.15 | Dec 12, 2018 | M | 16,249 | D | — | Feb 21, 2027 | Ordinary Shares | 16,249 | 34,764 | D |
Explanation of responses
- F1Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah.
- F2Options exercised were fully vested as of the date hereof.